RAPP
Rapport Therapeutics Inc

436
Loading...
Loading...
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
69

Frequently Asked Questions

What is Market Cap of Rapport Therapeutics Inc.?
What is the 52-week high for Rapport Therapeutics Inc.?
What is the 52-week low for Rapport Therapeutics Inc.?
What is Rapport Therapeutics Inc. stock price today?
What was Rapport Therapeutics Inc. stock price yesterday?
What is the PE ratio of Rapport Therapeutics Inc.?
What is the Price-to-Book ratio of Rapport Therapeutics Inc.?
What is the 50-day moving average of Rapport Therapeutics Inc.?
How many employess does Rapport Therapeutics Inc. has?

Latest RAPP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.